Clinical Trials Browser

Completed × Depression × Interleukin-2 × Clear all

NCT00352885 2018-09-14

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

Phase 4 Completed

20 enrolled 11 charts

Depression, Neoplasms